[go: up one dir, main page]

AR045557A1 - Sintesis selectivas de pirimidinas sustituidas con cf3 - Google Patents

Sintesis selectivas de pirimidinas sustituidas con cf3

Info

Publication number
AR045557A1
AR045557A1 ARP040103140A ARP040103140A AR045557A1 AR 045557 A1 AR045557 A1 AR 045557A1 AR P040103140 A ARP040103140 A AR P040103140A AR P040103140 A ARP040103140 A AR P040103140A AR 045557 A1 AR045557 A1 AR 045557A1
Authority
AR
Argentina
Prior art keywords
formula
group
compound
selective synthesis
pyrimidines
Prior art date
Application number
ARP040103140A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR045557A1 publication Critical patent/AR045557A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente se refiere a síntesis selectivas de pirimidinas sustituidas con CF3. El resto de 2,4-diamino-piridina es un componente corriente en una diversidad de moléculas biológicamente activas similares a fármacos y se ha encontrado que los derivados de pirimida son útiles en el tratamiento de un crecimiento anormal de células, tal como un cáncer, en mamíferos. Reivindicación 1: Un método de preparar un compuesto de la fórmula (1) en la que X2 es un grupo lábil, y R3 y R4 son sustituyentes seleccionados independientemente entre el conjunto que consta de H, un grupo aromático y un grupo alifático o tomados conjuntamente -NR3R4 pueden formar un anillo aromático o alifático de 4-11 miembros, en que el método comprende hacer reaccionar un compuesto de fórmula (2) con una amina de fórmula 3(HNR3R4) en la presencia de un ácido de Lewis y de una base no nucleófila para formar un compuesto de fórmula (1), en el que X1 es un grupo lábil.
ARP040103140A 2003-09-05 2004-09-02 Sintesis selectivas de pirimidinas sustituidas con cf3 AR045557A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50073303P 2003-09-05 2003-09-05

Publications (1)

Publication Number Publication Date
AR045557A1 true AR045557A1 (es) 2005-11-02

Family

ID=34272990

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103140A AR045557A1 (es) 2003-09-05 2004-09-02 Sintesis selectivas de pirimidinas sustituidas con cf3

Country Status (24)

Country Link
US (1) US7122670B2 (es)
EP (1) EP1663991B1 (es)
JP (1) JP4842816B2 (es)
KR (1) KR100694732B1 (es)
CN (1) CN100465164C (es)
AR (1) AR045557A1 (es)
BR (1) BRPI0414059B8 (es)
CA (1) CA2537373C (es)
CO (1) CO5650237A2 (es)
CY (1) CY1106370T1 (es)
DE (1) DE602004004287T2 (es)
DK (1) DK1663991T3 (es)
ES (1) ES2276344T3 (es)
HK (1) HK1091824A1 (es)
IL (1) IL173363A (es)
MX (1) MXPA06002552A (es)
NO (1) NO334383B1 (es)
NZ (1) NZ544969A (es)
PL (1) PL1663991T3 (es)
PT (1) PT1663991E (es)
RU (1) RU2315759C2 (es)
TW (1) TWI283667B (es)
WO (1) WO2005023780A1 (es)
ZA (1) ZA200600747B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2529611C (en) * 2002-12-20 2009-12-15 Pfizer Products Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
US20060205945A1 (en) * 2004-05-14 2006-09-14 Pfizer Inc Pyrimidine derivatives for the treatment of abnormal cell growth
JP4778717B2 (ja) * 2005-03-25 2011-09-21 富士フイルム株式会社 複素環式化合物の製造方法
DE102007010801A1 (de) 2007-03-02 2008-09-04 Bayer Cropscience Ag Diaminopyrimidine als Fungizide
AP2009005010A0 (en) * 2007-04-18 2009-10-31 Pfizer Prod Inc Sulfonyl amide derivatives for the treatment of abnormal cell growth
KR101294731B1 (ko) * 2007-06-04 2013-08-16 삼성디스플레이 주식회사 어레이 기판, 이를 갖는 표시패널 및 이의 제조방법
WO2009115583A1 (en) * 2008-03-20 2009-09-24 Boehringer Ingelheim International Gmbh Regioselective preparation of substituted pyrimidines
UY31714A (es) 2008-03-20 2009-11-10 Boehringer Ingelheim Int Preparación selectiva de pirimidinas sustituidas
DE102009006643A1 (de) 2009-01-29 2010-08-05 Saltigo Gmbh Herstellung von halogenierten N-heteroaromatischen Polyhalogenderivaten
TW201100441A (en) * 2009-06-01 2011-01-01 Osi Pharm Inc Amino pyrimidine anticancer compounds
WO2011018517A1 (en) 2009-08-14 2011-02-17 Boehringer Ingelheim International Gmbh Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives
US8933227B2 (en) 2009-08-14 2015-01-13 Boehringer Ingelheim International Gmbh Selective synthesis of functionalized pyrimidines
EP2646448B1 (en) 2010-11-29 2017-08-30 OSI Pharmaceuticals, LLC Macrocyclic kinase inhibitors
UY33817A (es) 2010-12-21 2012-07-31 Boehringer Ingelheim Int ?nuevas oxindolpirimidinas bencílicas?.
ES2724525T3 (es) 2011-02-17 2019-09-11 Cancer Therapeutics Crc Pty Ltd Inhibidores selectivos de FAK
ES2691673T3 (es) 2011-02-17 2018-11-28 Cancer Therapeutics Crc Pty Limited Inhibidores de Fak
WO2014126954A1 (en) 2013-02-13 2014-08-21 OSI Pharmaceuticals, LLC Regioselective synthesis of substituted pyrimidines
GB2566622B (en) * 2014-05-08 2019-07-10 Tosoh F Tech Inc 5-(Trifluoromethyl)pyrimidine derivatives and method for producing same
JP6391985B2 (ja) * 2014-05-16 2018-09-19 東ソー・ファインケム株式会社 2−置換−4−(2,2,2−トリフルオロエトキシ)−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法
JP6391988B2 (ja) * 2014-05-21 2018-09-19 東ソー・ファインケム株式会社 5−(トリフルオロメチル)ピリミジン誘導体の製造方法及び新規5−(トリフルオロメチル)ピリミジン誘導体
CN108440499A (zh) * 2018-03-22 2018-08-24 盐城师范学院 一种色瑞替尼及其关键中间体的制备方法
CN114213339B (zh) * 2021-12-20 2023-10-31 苏州康纯医药科技有限公司 一种表皮细胞生长因子受体突变抑制剂的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030909A1 (en) * 2001-09-25 2003-04-17 Bayer Pharmaceuticals Corporation 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
ES2314106T3 (es) * 2001-10-17 2009-03-16 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Derivados de pirimidina, agentes farmaceuticos que contiene dichos compuestos, uso y metodo para su obtencion.

Also Published As

Publication number Publication date
RU2315759C2 (ru) 2008-01-27
KR100694732B1 (ko) 2007-03-14
JP4842816B2 (ja) 2011-12-21
IL173363A0 (en) 2006-06-11
BRPI0414059A (pt) 2006-10-24
RU2006106727A (ru) 2006-06-27
PT1663991E (pt) 2007-02-28
AU2004270480A1 (en) 2005-03-17
TWI283667B (en) 2007-07-11
US20050101620A1 (en) 2005-05-12
US7122670B2 (en) 2006-10-17
CY1106370T1 (el) 2011-10-12
EP1663991A1 (en) 2006-06-07
NO334383B1 (no) 2014-02-24
EP1663991B1 (en) 2007-01-10
CA2537373C (en) 2009-10-20
NZ544969A (en) 2008-07-31
NO20061509L (no) 2006-04-03
DE602004004287T2 (de) 2007-06-21
TW200514773A (en) 2005-05-01
CN1845906A (zh) 2006-10-11
PL1663991T3 (pl) 2007-04-30
HK1091824A1 (en) 2007-01-26
CA2537373A1 (en) 2005-03-17
DE602004004287D1 (de) 2007-02-22
BRPI0414059B8 (pt) 2021-05-25
CO5650237A2 (es) 2006-06-30
BRPI0414059B1 (pt) 2018-11-06
IL173363A (en) 2010-05-31
MXPA06002552A (es) 2006-06-20
DK1663991T3 (da) 2007-04-10
JP2007504211A (ja) 2007-03-01
ZA200600747B (en) 2007-03-28
CN100465164C (zh) 2009-03-04
WO2005023780A1 (en) 2005-03-17
KR20060030918A (ko) 2006-04-11
ES2276344T3 (es) 2007-06-16

Similar Documents

Publication Publication Date Title
AR045557A1 (es) Sintesis selectivas de pirimidinas sustituidas con cf3
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
CY1117481T1 (el) Φαρμακευτικη συνθεση που περιεχει παραγωγο κινολινης
ECSP067053A (es) 1-aza-biciclo[3.3.1]nonanos
ECSP055633A (es) Nuevos derivados de benzoimidazolutiles como angentes antiproliferativos
CY1108792T1 (el) Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη
PT1261602E (pt) Derivados imidazol-2-carboxamida como inibidores de cinase raf
UY26872A1 (es) Derivados de la 4- fenil piridina
DK1678119T3 (da) Fremgangsmåde til fremstilling af 2-dihalogenacyl-3-amino-acrylsyreestere og 3-dihalogenmethyl-pyrazol-4-carboxylsyreestere
PE20080688A1 (es) Derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas como antagonistas de trpv1 y su preparacion
EA201000413A1 (ru) Способ получения производных лактамида, новые производные лактамида и препараты, содержащие производные лактамида
EA201170098A1 (ru) Замещенные производные алкилпиримидин-4-она
CY1115643T1 (el) Διεγερτης νευρογενεσης ή θεραπευτικος παραγων νευροπαθειας που περιλαμβανει παραγωγα αλκυλ αιθερα ή αλας αυτου
AR045868A1 (es) Proceso para preparar compuestos de ocarbamoilo en presencia de grupo amina activa
ATE449069T1 (de) Aminopropanolderivate
MX2010003148A (es) Procedimiento para la preparacion de diamidas de acido sulfonico.
AR027607A1 (es) Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica
EA201001087A1 (ru) Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их
EA200971062A1 (ru) Производные ариламидпиримидона
EA200600487A1 (ru) Соединения инданилпиперазина, способ их получения и содержащие их фармацевтические композиции
PA8589801A1 (es) Aminoalcoxiindoles
CR7249A (es) Derivados de diamina, proceso para producir los derivados de diamina, y funguicidas que contienen los derivados de diamina como ingrediente activo
CO5640114A2 (es) 4-(2,4-dicloro-5-metoxifenil)amino -6-alcoxi-3-quinolincarbonitrilos para el tratamiento de lesiones isquemicas
AR071005A1 (es) Preparacion selectiva de pirimidinas sustituidas
RU2014101999A (ru) Производные пиперазина, способы их получения и их применение в лечении инсулинорезистентности

Legal Events

Date Code Title Description
FA Abandonment or withdrawal